Name: Accelerate Global Clinical Development with Asia-Pacific (APAC)
Start: 2026-11-24T10:00:00.000+01:00
End: 2026-11-24T12:00:00.000+01:00
Location: Online

DERODES PARTNERS

, Derodes Partners and PSCC are hosting a 

2-hour executive webinar: "Accelerate Global Clinical Development with ASIA-PACIFIC (APAC)"

Clinical development is being redrawn. According to the IQVIA Institute (

), Western Europe is still the most-used region for clinical trials, but its share of trial country use has dropped 17% since 2019. Asia-Pacific (APAC) keeps gaining ground, and deals between China-based and international biopharma companies hit an all-time high in 2025.

Why integrate APAC into your clinical development plan?

For European biotechs, the question has shifted from whether to include APAC to how and when.

We'll focus on oncology and bring together industry and academic views from the region:

, CEO, Expecto Health Sciences (part of Southern Star Research), a CRO operating across Asia, Australia and New Zealand

, Section Head, Asian Partnerships Section, Department of International Clinical Development, National Cancer Center Hospital, Japan

Singapore Translational Cancer Consortium (STCC)

, Chairman, Division of Medical Oncology National Cancer Centre Singapore

Link for access to Webinar will be shared 1 week before the event.

For more details, please contact Carine LA (carine.la[a]